INTERNATIONAL PATENT: MEDIMMUNE LIMITED FILES APPLICATION FOR "ANTI-IL5R-ALPHA TREATMENT FOR ACUTE EXACERBATIONS OF ASTHMA AND COPD"

GENEVA, March 17 -- MEDIMMUNE LIMITED (1 Francis Crick AvenueCambridge Biomedical CampusCambridge CB2 0AA) filed a patent application (PCT/IB2025/058958) for "ANTI-IL5R-ALPHA TREATMENT FOR ACUTE EXACERBATIONS OF ASTHMA AND COPD" on Sep 05, 2025. With publication no. WO/2026/053166, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAFADHEL, Mona (c/o The Chancellor, Masters and Scholars of the University of OxfordWellington SquareOxford OX1 2JD)

Abstract: Provided herein are methods of treating acute exacerbations of asthm...